Funder: National Institutes of Health (NIH)

Due Dates: October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission)

Funding Amounts: Up to $275,000 total direct costs over 2 years, with no more than $200,000 in any single year.

Summary: Supports exploratory research to elucidate neurobiological and behavioral mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease and related dementias to identify novel therapeutic targets.

Key Information: Clinical trial optional; encourages high-risk/high-reward projects without preliminary data; data sharing via NIH repositories required.